ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT06902558 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease

Interventions

DRUG: ABBV-CLS-628
DRUG: Placebo

Sponsor

Calico Life Sciences LLC